Abbott's third-quarter earnings edge past Street

Apart from the St. Jude deal, Abbott is buying molecular diagnostic company Alere Inc for $5.80 billion. The Abbott Park, Illinois-based company's stock was down about 2 percent in premarket trading on Wednesday. St. Jude, which also reported its quarterly results, posted a quarterly adjusted profit of 99 cents, missing the average Wall Street estimate by 2 cents.